Verve Therapeutics
AcquiredWe are on a mission to protect the world from cardiovascular disease
Boston, United States · Founded 2018 · $428.5M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 201–500
- Founded
- 2018
- Business Model
- B2B
- Website
- vervetx.com
- Total Funding
- $428.5M
- Last Round
- $213.0M Series COct 2024
- Rounds
- 4
- Acquisition Date
- Jun 2025
About
Verve Therapeutics is a clinical-stage company developing single-course, in vivo gene editing medicines to permanently lower cardiovascular disease risk. Its platform uses base editing to precisely inactivate genes in the liver — such as PCSK9 and ANGPTL3 — that contribute to atherosclerotic cardiovascular disease. Lead programs VERVE-101 and VERVE-102 are advancing through Phase 1b clinical trials with FDA Fast Track Designation.
Summary
Verve Therapeutics is a Biotech company based in Boston, United States, founded in 2018. It has raised $428.5M in total across 4 rounds, most recently a $213.0M Series C round in Oct 2024. Investors include GV, Foresite Capital and ARCH Venture Partners.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jun 2025
Sign up to see all 6 rounds
Series A through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/verve-therapeutics"><img src="https://indexed.vc/api/badge/company/verve-therapeutics" alt="Verve Therapeutics on Indexed.vc" width="260" height="76" /></a>